NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that Aetna Healthcare has authorized a claim for reimbursement for its Portable Neuromodulation Stimulator (PoNS) Device, marking a significant milestone for the company and the multiple sclerosis (MS) community. Aetna becomes the third major healthcare payer, joining Anthem and UnitedHealthcare, in recognizing the device for out-of-network reimbursement at a negotiated price of $18,350.
The PoNS Device, designed for multiple sclerosis patients, aids in gait improvement through a non-invasive neuromodulation approach. Reimbursement approval from major payers signals growing acceptance of this innovative treatment in commercial healthcare networks.
“This recent reimbursement approval marks a significant milestone for Helius and the MS community,” said Dane Andreeff, President and CEO of Helius Medical Technologies. “We are actively pursuing broader in-network coverage at the list price while negotiating reimbursements on a case-by-case basis. Our goal is to expand patient access and align commercial payment rates with those already offered by the VA/DoD at $26,228.”
The out-of-network claim approved by Aetna reflects reimbursement progress for PoNS but remains an intermediate step in Helius’ strategy to secure consistent coverage across major commercial healthcare payers. The company aims to strengthen in-network agreements to make the device accessible at the full list price, while also advocating for Medicare and CMS reimbursement to support patients reliant on federal healthcare systems.
Helius’ device and its potential reimbursement approvals represent a critical advancement for MS patients who seek innovative treatments to improve mobility and quality of life. By expanding partnerships in the healthcare industry, Helius continues to build toward improving treatment accessibility and addressing barriers for those impacted by neurological conditions.
The PoNS Device is available with prescriptive authorization for qualified patients, and Helius remains laser-focused on streamlining the reimbursement process to ensure that all MS patients have equal access to this cutting-edge technology.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.